Lv21
140 积分 2026-06-22 加入
The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)
27天前
已完结
Metformin Improves the Prerequisites for FGF21 Signaling in Patients with Type 2 Diabetes
30天前
已完结
Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial
1个月前
已完结
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
1个月前
已完结
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
1个月前
已完结
MASLD/MASH and type 2 diabetes: Two sides of the same coin? From single PPAR to pan-PPAR agonists
1个月前
已完结
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
1个月前
已完结
Fibrosis: from mechanisms to medicines
1个月前
已完结
PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α
1个月前
已完结
Engineering of a femtomolar affinity binding protein to human serum albumin
1个月前
已完结
皖公网安备34019202002308
